Joshua T Bartoe, DVM, MS

Joshua T Bartoe, DVM, MS
Joshua T Bartoe, DVM, MS

Community Assistant Professor, Department of Biomedical Sciences

Contact Information

Email:

Biosketch

Josh Bartoe, DVM, is currently Vice President of Ophthalmology Services and Attending Veterinarian at Northern Biomedical Research, headquartered in Norton Shores, Michigan. NBR is a contract research organization, based on the central western coast of Michigan, focused on targeted delivery expertise for CNS, ophthalmology, cardiology, and orthopedic indications. He is also the Director of Finance for Northern Biomolecular Services, also of Norton Shores. NBS is a contract research analytical laboratory focused on providing comprehensive, GLP-compliant qPCR-qRT-PCR assays to support development of gene, cell, and other biological therapeutics.

Dr. Bartoe is a Diplomate of the American College of Veterinary Ophthalmologists and started his career in academic medicine with Michigan State University College of Veterinary Medicine. During his 10 years with MSU, he also provided consulting ophthalmology services to MPI Research. He left MSU to become the Director of Ophthalmology Services at MPI in 2014. Following the Charles River acquisition of MPI, Dr. Bartoe was selected to lead the global CRL ocular center of excellence and was promoted to Senior Director of Ophthalmology Services for the Mattawan, Michigan, site. He has authored more than 30 peer-reviewed manuscripts focused primarily on the ocular gene therapy space, along with 6 textbook chapters. He is an active member of the Association for Research in Vision and Ophthalmology, American Society of Gene and Cell Therapy, Society of Toxicology, and the American College of Veterinary Ophthalmologists.

  • Education and Training
    • MS 2001, Biology, The Ohio State University
    • DVM 2001, The Ohio State University
    • BS 1997, Biology, University of Minnesota-Duluth

  • Research
    • Veterinary Toxicology
    • Ophthalmology

  • Publications

    • Booler H., Ramos M.F., Bartoe J., Teixeira L. The Eye Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 4: Toxicologic Pathology of Organ Systems. 2024:739-832.

    • Booler H.S., Lejeune T., Turner O., Saravanan C., Bartoe J.T., Bolon B. Toxicologic Pathology. 2024;52:506-522.

    • Schafer K.A., Atzpodien E., Bach U., Bartoe J., Booler H., Brassard J., Farman C., Kochi M., Lejeune T., Meseck E., Nolte T., Ramos M., Short B., Sorden S., Teixeira L., Turner O., Walling B., Yekkala K., Yoshizawa K. Toxicologic Pathology. 2024;52:368-455.

    • Meany E.L., Andaya R., Tang S., Kasse C.M., Fuji R.N., Grosskopf A.K., d'Aquino A.L., Bartoe J.T., Ybarra R., Shelton A., Pederson Z., Hu C., Leung D., Nagapudi K., Ubhayakar S., Wright M., Yen C.W., Appel E.A. Injectable Polymer-Nanoparticle Hydrogel for the Sustained Intravitreal Delivery of Bimatoprost Advanced Therapeutics. 2023;6

    • Miyadera K., Santana E., Roszak K., Iffrig S., Visel M., Iwabe S., Boyd R.F., Bartoe J.T., Sato Y., Gray A., Ripolles-Garcia A., Dufour V.L., Byrne L.C., Flannery J.G., Beltran W.A., Aguirre G.D. Proceedings of the National Academy of Sciences of the United States of America. 2022;119

    • Pavlou M., Schön C., Occelli L.M., Rossi A., Meumann N., Boyd R.F., Bartoe J.T., Siedlecki J., Gerhardt M.J., Babutzka S., Bogedein J., Wagner J.E., Priglinger S.G., Biel M., Petersen-Jones S.M., Büning H., Michalakis S. EMBO Molecular Medicine. 2021;13

    • Zeng Y., Boyd R., Bartoe J., Wiley H.E., Marangoni D., Wei L.L., Sieving P.A. “Para-retinal” Vector Administration into the Deep Vitreous Enhances Retinal Transgene Expression Molecular Therapy - Methods and Clinical Development. 2020;18:422-427.

    • Park S.A., Sledge D., Monahan C., Bartoe J.T., Komáromy A.M. BMC Veterinary Research. 2019;15(1)

    • Pierce K.E., Curran P.G., Zelinka C.P., Fischer A.J., Petersen-Jones S.M., Bartoe J.T. Advances in Experimental Medicine and Biology. 2019;1185:371-376.

    • Bartoe J.T., Cook C.S., Bussieres M., Munger R.J., Brown M.H. Harmonization of lesion nomenclature in laboratory animals Standards for Ocular Toxicology and Inflammation. 2018:141-168.

    • Berkowski W., Langohr I., Pease A., Bartoe J. Journal of the American Veterinary Medical Association. 2018;252(3):324-329.

    • Gilger B.C., Bartoe J.T., Seth Eaton J., Boyd R. Standard operating procedures for common laboratory animal ocular procedures Standards for Ocular Toxicology and Inflammation. 2018:27-44.

    • Gilger B.C., Brown M.H., Munger R.J., Bartoe J.T., Bussieres M., Cook C.S. Standards for conducting ophthalmic examinations in laboratory animals Standards for Ocular Toxicology and Inflammation. 2018:141-168.

    • Mowat F.M., Bartoe J.T. Adnexal Surgery Equine Surgery, Fifth Edition. 2018:927-956.

    • Stonex T.M., Bartoe J.T., Aguirre G.D. Veterinary Ophthalmology. 2018;21(1):104-107.

    • Wilkie D.A., Gilger B.C., Bartoe J.T. Standards for conducting ophthalmic examinations in laboratory animals Standards for Ocular Toxicology and Inflammation. 2018:1-25.

    • Mowat F., Occelli L., Bartoe J., Gervais K., Bruewer A., Querubin J., Dinculescu A., Boye S., Hauswirth W., Petersen-Jones S. Gene therapy in a large animal model of PDE6A-retinitis pigmentosa Frontiers in Neuroscience. 2017;11(JUN)

    • Winkler P.A., Davis J.A., Petersen-Jones S.M., Venta P.J., Bartoe J.T. Veterinary Ophthalmology. 2017;20(4):372-376.

    • Boyd R., Boye S., Conlon T., Erger K., Sledge D., Langohr I., Hauswirth W., Komáromy A., Petersen-Jones S., Bartoe J. Gene Therapy. 2016;23(6):548-556.

    • Boyd R., Sledge D., Boye S., Hauswirth W., Komáromy A., Petersen-Jones S., Bartoe J. Erratum: Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs (Gene Therapy (2016) 23 (223-230)) DOI:10.1038/gt.2015.96) Gene Therapy. 2016;23(4):400.

    • Boyd R.F., Sledge D.G., Boye S.L., Hauswirth W.W., Komáromy A.M., Petersen-Jones S.M., Bartoe J.T. Gene Therapy. 2016;23(2):223-230.

    • Marangoni D., Bush R.A., Zeng Y., Wei L.L., Ziccardi L., Vijayasarathy C., Bartoe J.T., Palyada K., Santos M., Hiriyanna S., Wu Z., Colosi P., Sieving P.A. Ocular and systemic safety of a recombinant AAV8 vector for X-linked retinoschisis gene therapy: GLP studies in rabbits and Rs1-KO mice Molecular Therapy Methods and Clinical Development. 2016;5

    • Pierce K.E., Wilkie D.A., Gemensky-Metzler A.J., Curran P., Townsend W.M., Petersen-Jones S.M., Bartoe J.T. Veterinary ophthalmology. 2016;19:77-85.

    • Dawson-Baglien E., Winkler P., Bruewer A., Petersen-Jones S., Bartoe J. Veterinary ophthalmology. 2015;18(4):285-290.

    • Minella A.L., Mowat F.M., Willett K.L., Sledge D., Bartoe J.T., Bennett J., Petersen-Jones S.M. Gene Therapy. 2014;21(10):913-920.

    • Mowat F.M., Gornik K.R., Dinculescu A., Boye S.L., Hauswirth W.W., Petersen-Jones S.M., Bartoe J.T. Gene Therapy. 2014;21(1):96-105.

    • Winkler P., Gornik K., Ramsey D., Dubielzig R., Venta P., Petersen-Jones S., Bartoe J. PLoS ONE. 2014;9(3)

    • Annear M.J., Gornik K.R., Venturi F., Hauptman J.G., Bartoe J.T., Petersen-Jones S.M. Veterinary Ophthalmology. 2013;16(5):324-328.

    • Annear M.J., Mowat F.M., Bartoe J.T., Querubin J., Azam S.A., Basche M., Curran P., Smith A.J., Bainbridge J.W.B., Ali R.R., Petersen-Jones S.M. Human Gene Therapy. 2013;24(10):883-893.

    • Bruewer A., Mowat F., Bartoe J., Boye S., Hauswirth W., Petersen-Jones S. PLoS ONE. 2013;8(4)

    • Mowat F.M., Breuwer A.R., Bartoe J.T., Annear M.J., Zhang Z., Smith A.J., Bainbridge J.W.B., Petersen-Jones S.M., Ali R.R. Gene Therapy. 2013;20(5):545-555.

    • Winkler P.A., Bartoe J.T., Quinones C.R., Venta P.J., Petersen-Jones S.M. Journal of Negative Results in BioMedicine. 2013;12(1)

    • Winkler P.A., Ekenstedt K.J., Occelli L.M., Frattaroli A.V., Bartoe J.T., Venta P.J., Petersen-Jones S.M. PLoS ONE. 2013;8(8)

    • Mowat F., Bartoe J.T. Adnexal Surgery Equine Surgery, Fourth Edition. 2012:744-770.

    • Petersen-Jones S., Annear M., Bartoe J., Mowat F., Barker S., Smith A., Bainbridge J., Ali R. Advances in Experimental Medicine and Biology. 2012;723:177-182.

    • Townsend W.M., Jacobi S., Bartoe J.T. Equine Veterinary Journal. 2012;44(2):238-243.

    • Annear M.J., Bartoe J.T., Barker S.E., Smith A.J., Curran P., Bainbridge J.W., Ali R.R., Petersen-Jones S.M. Gene Therapy. 2011;18(1):53-61.

    • Petersen-Jones S.M., Bartoe J.T., Fischer A.J., Scott M., Boye S.L., Chiodo V., Hauswirth W.W. Molecular Vision. 2009;15:1835-1842.

    • Bartoe J.T., Brightman A.H., Davidson H.J. Veterinary Ophthalmology. 2007;10(2):127-131.

    • Bartoe J., Davidson H., Horton M., Jung Y., Brightman A. Veterinary Ophthalmology. 2005;8(4):247-252.

    • Clark-Price S., Cox J., Bartoe J., Davis E. Journal of the American Veterinary Medical Association. 2004;224(3):407-410+371.

    • Zhang W., Nisbet J.W., Albrecht B., Ding W., Kashanchi F., Bartoe J.T., Lairmore M.D. Journal of Virology. 2001;75(20):9885-9895.

    • Bartoe J.T., Albrecht B., Collins N.D., Robek M.D., Ratner L., Green P.L., Lairmore M.D. Journal of Virology. 2000;74(3):1094-1100.

    • Lairmore M.D., Albrecht B., D'Souza C., Nisbet J.W., Ding W., Bartoe J.T., Green P.L., Zhang W. AIDS Research and Human Retroviruses. 2000;16(16):1757-1764.

    • Zhang W., Nisbet J.W., Bartoe J.T., Ding W., Lairmore M.D. Journal of Virology. 2000;74(23):11270-11277.